Core Laboratories, Inc.

  • Market Cap: Micro Cap
  • Industry: Oil
  • ISIN: US21867A1051
USD
16.49
0.07 (0.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Core Laboratories, Inc. stock-summary
stock-summary
Core Laboratories, Inc.
Oil
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
Company Coordinates stock-summary
Company Details
Tower a, Level 9, Strawinskylaan 913 , AMSTERDAM None : 1077 XX
stock-summary
Tel: 31 24 203191
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 49 Schemes (56.68%)

Foreign Institutions

Held by 78 Foreign Institutions (9.38%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Lawrence Bruno
Chairman of the Supervisory Board, Chief Executive Officer
Ms. Martha Carnes
Proposed Independent Lead Director
Mr. Gregory Barnett
Independent Member of the Supervisory Board
Mr. Harvey Klingensmith
Independent Member of the Supervisory Board
Mr. Michael Straughen
Independent Member of the Supervisory Board
Mrs. Monique Van Dijken Eeuwijk
Independent Member of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
130 Million
(Quarterly Results - Jun 2025)
Net Profit:
11 Million
stock-summary
Industry

Oil

stock-summary
Market cap

USD 584 Million (Micro Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

63.91%

stock-summary
Debt Equity

0.40

stock-summary
Return on Equity

9.84%

stock-summary
Price to Book

2.24